Not Rated
|
Fund Size
(1.22% of Investment in Category)
|
Expense Ratio
(2.13% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 10-Nov-25 | 10166.90 | 1.67% | - | 1.30% | 61/242 |
| 1 Month | 17-Oct-25 | 10101.50 | 1.02% | - | 1.15% | 118/235 |
| 3 Month | 14-Aug-25 | 10119.00 | 1.19% | - | 4.98% | 218/235 |
| 6 Month | 16-May-25 | 10756.50 | 7.57% | - | 6.28% | 64/225 |
| YTD | 01-Jan-25 | 10134.10 | 1.34% | - | 4.93% | 132/211 |
| 1 Year | 14-Nov-24 | 10868.20 | 8.68% | 8.61% | 7.67% | 76/198 |
| 2 Year | 17-Nov-23 | 16130.40 | 61.30% | 26.96% | 18.31% | 8/154 |
| 3 Year | 17-Nov-22 | 21068.70 | 110.69% | 28.17% | 19.03% | 6/128 |
| 5 Year | 17-Nov-20 | 25570.20 | 155.70% | 20.64% | 20.73% | 42/104 |
| Since Inception | 13-Jul-18 | 40810.00 | 308.10% | 21.08% | 12.97% | 23/216 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 14-Nov-24 | 12000 | 12779.71 | 6.5 % | 12.17 % |
| 2 Year | 17-Nov-23 | 24000 | 28488.99 | 18.7 % | 17.4 % |
| 3 Year | 17-Nov-22 | 36000 | 52311.54 | 45.31 % | 25.78 % |
| 5 Year | 17-Nov-20 | 60000 | 103734.85 | 72.89 % | 22.03 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 7648 | 11.88% | 0.30% | 13.83% (Dec 2024) | 11.58% (Sep 2025) | 45.24 L | 0.00 |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 6065.4 | 9.42% | 0.32% | 9.66% (May 2025) | 8.28% (Jan 2025) | 50.65 L | 4.32 L |
| Divis Laboratories Ltd. | Pharmaceuticals | 5474.9 | 8.50% | -0.25% | 9.23% (Aug 2025) | 1.86% (Nov 2024) | 8.13 L | -1.45 L |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 4904.1 | 7.62% | -0.63% | 8.25% (Sep 2025) | 4.87% (Jan 2025) | 43.06 L | -4.34 L |
| Cipla Ltd. | Pharmaceuticals | 4255.3 | 6.61% | -0.31% | 9.71% (Jan 2025) | 6.61% (Oct 2025) | 28.34 L | -0.32 L |
| Lupin Ltd. | Pharmaceuticals | 3474.7 | 5.40% | -0.03% | 5.44% (Aug 2025) | 3.79% (Jun 2025) | 17.70 L | 0.00 |
| Alkem Laboratories Ltd. | Pharmaceuticals | 2561.4 | 3.98% | -0.07% | 4.49% (Feb 2025) | 3.83% (Jul 2025) | 4.65 L | 0.00 |
| Biocon Ltd. | Pharmaceuticals | 2113.6 | 3.28% | 0.17% | 5.02% (Jun 2025) | 1.36% (Feb 2025) | 56.80 L | 0.00 |
| Mankind Pharma Ltd. | Pharmaceuticals | 1795.1 | 2.79% | -0.16% | 4.2% (Jun 2025) | 0.62% (Nov 2024) | 7.53 L | 0.00 |
| Zydus Lifesciences Ltd. | Pharmaceuticals | 1716.2 | 2.67% | -0.11% | 4.01% (May 2025) | 2.67% (Oct 2025) | 17.61 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 3.18% |
| Margin | Margin | 0.13% |
| Net Receivables | Net Receivables | -0.41% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 421.51 | -0.53 | 9.03 | 40.23 | 45.35 | 34.04 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 273.51 | -0.11 | 1.72 | 13.46 | 29.02 | 14.83 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 680.73 | 4.17 | 7.89 | 18.36 | 25.68 | 0.00 |
| Franklin Asian Equity Fund - Growth | NA | 297.12 | 2.07 | 9.06 | 17.83 | 24.21 | 12.56 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1733.63 | -1.31 | 5.52 | 17.95 | 22.83 | 0.00 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 9273.44 | 2.51 | 5.70 | 10.96 | 21.54 | 19.77 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 333.18 | 3.46 | 7.61 | 8.37 | 21.45 | 13.60 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1518.73 | 1.07 | 5.81 | 6.92 | 21.05 | 0.00 |
| Mirae Asset Banking and Financial Services Fund - Growth | NA | 2130.33 | 3.13 | 6.67 | 9.03 | 20.75 | 17.55 |
| HDFC Banking and Financial Services Fund - Growth | NA | 4362.29 | 3.54 | 6.68 | 8.24 | 18.99 | 16.97 |
Out of 176 mutual fund schemes offered by this AMC, 10 is/are ranked 5 * , 8 is/are ranked 4 * , 15 is/are ranked 3 * , 5 is/are ranked 2 * , 2 is/are ranked 1 * , and 136 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| ICICI Prudential Large Cap Fund - Growth | 5 | 75863.08 | 1.76 | 5.36 | 5.52 | 11.66 | 18.08 |
| ICICI Prudential Multi-Asset Fund - Growth | 3 | 71900.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| ICICI Prudential Multi-Asset Fund - Growth | 3 | 71900.48 | 0.84 | 7.11 | 8.02 | 16.71 | 19.44 |
| ICICI Prudential Balanced Advantage Fund - Growth | 2 | 68449.94 | 0.67 | 4.43 | 5.52 | 11.47 | 13.42 |
| ICICI Prudential Value Fund - Growth | 5 | 57934.73 | 2.50 | 5.89 | 6.39 | 12.41 | 21.39 |
| ICICI Prudential Liquid Fund - Growth | 3 | 50120.55 | 0.48 | 1.43 | 2.96 | 6.61 | 6.97 |
| ICICI Prudential Equity & Debt Fund - Growth | 5 | 48071.30 | 0.70 | 5.02 | 5.74 | 12.99 | 19.13 |
| ICICI Prudential Money Market Fund - Growth | 4 | 35011.13 | 0.50 | 1.53 | 3.29 | 7.56 | 7.54 |
| ICICI Prudential Nifty 50 ETF | 5 | 34935.53 | 1.30 | 5.79 | 4.91 | 11.79 | 13.60 |
| ICICI Prudential Nifty 50 ETF | 5 | 34935.53 | 1.30 | 5.79 | 4.91 | 11.79 | 13.60 |